These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18781599)

  • 21. The natriuretic peptides in cardiovascular medicine.
    Munagala VK; Burnett JC; Redfield MM
    Curr Probl Cardiol; 2004 Dec; 29(12):707-69. PubMed ID: 15550914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues.
    Yandle TG; Richards AM
    Clin Chim Acta; 2015 Aug; 448():195-205. PubMed ID: 26160054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natriuretic peptides in the pathophysiology of congestive heart failure.
    Chen HH; Burnett JC
    Curr Cardiol Rep; 2000 May; 2(3):198-205. PubMed ID: 10980893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
    Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
    Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure.
    Yoshimura M; Yasue H; Ogawa H
    Can J Physiol Pharmacol; 2001 Aug; 79(8):730-5. PubMed ID: 11558682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review.
    Woods RL
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):791-4. PubMed ID: 15566395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NT-ProBNP: the mechanism behind the marker.
    Hall C
    J Card Fail; 2005 Jun; 11(5 Suppl):S81-3. PubMed ID: 15948107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.
    Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):519-29. PubMed ID: 21604179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure.
    Mikkelsen KV; Bie P; Møller JE; Videbaek L; Villadsen HD; Haghfelt T
    Int J Cardiol; 2006 Jun; 110(3):324-33. PubMed ID: 16213609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review.
    Santaguida PL; Don-Wauchope AC; Ali U; Oremus M; Brown JA; Bustamam A; Hill SA; Booth RA; Sohel N; McKelvie R; Balion C; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):507-19. PubMed ID: 25052418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemistry of B-type natriuretic peptide--where are we now?
    Mair J
    Clin Chem Lab Med; 2008; 46(11):1507-14. PubMed ID: 18842106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of natriuretic peptides in heart failure].
    Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
    Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arg13 of B-type natriuretic Peptide reciprocally modulates binding to guanylyl cyclase but not clearance receptors.
    Dickey DM; Barbieri KA; McGuirk CM; Potter LR
    Mol Pharmacol; 2010 Sep; 78(3):431-5. PubMed ID: 20530652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-type natriuretic peptide. Guided vs. conventional care in outpatients with chronic heart failure: a retrospective study.
    De Vecchis R; Esposito C; Di Biase G; Ariano C
    Minerva Cardioangiol; 2013 Aug; 61(4):437-49. PubMed ID: 23846010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.
    Wayne Causey M; Singh N
    Semin Vasc Surg; 2014 Dec; 27(3-4):143-7. PubMed ID: 26073822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.
    Li D; Lu CJ; Hao G; Wright H; Woodward L; Liu K; Vergari E; Surdo NC; Herring N; Zaccolo M; Paterson DJ
    Hypertension; 2015 Jul; 66(1):190-8. PubMed ID: 25916722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
    Kjaer A; Hesse B
    Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.